New research has found that the use of GLP-1 receptor agonists, a class of medications commonly prescribed for patients with ...

Heart failure is a major contributor to the global burden of cardiovascular disease, affecting more than 55 million people. Prevalence has more than doubled over the past three decades, and it is the ...

EBR Wise CRT system helps both sides of the heart stay in rhythm when pacemaker alone doesn't work. St. David's Medical ...

The rate of death from any cause was 27.2% with digitoxin and 29.5% with placebo (HR 0.86, 95% CI 0.69-1.07). The rate of a first hospital admission for worsening heart failure was 28.1% with ...

MILLIONS of Brits with a ‘silent’ disease could be at risk of heart failure. An estimated one in five people have MASLD ...

Heart disease has change since the 1970s as surgeries, medications and transplants have people living longer. Lifestyle and ...

But to their knowledge, this is the first study that has tested gene therapy on a heart disease model in non-human primates. The team also believes that this approach may be particularly effective for ...

As the treatment modalities, scope and complexity of clinical trials for congestive heart failure (CHF) drug development increase, so does the need for precision and accuracy in endpoint definitions ...

United Regional Health Care System has made significant strides in combating heart disease, the leading cause of death in the ...

A 68-year-old’s routine life took a sudden turn when he developed acute heart and kidney failure, but a rare medical treatment gave him a second chance at life.

After suffering heart failure from a sinus infection, 11-year-old Ava Cooper successfully received a heart transplant and ...

Heart failure costs the nation an estimated $30.7 billion each year. This includes the cost of health care services, medications to treat heart failure and missed days of work. And the prevalence ...